featured
Vascular Events After ACS: Lipoprotein(a) and Alirocumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial
Circulation 2020 Mar 29;[EPub Ahead of Print], GG Schwartz, PG Steg, M Szarek, VA Bittner, R Diaz, SG Goodman, YU Kim, JW Jukema, R Pordy, MT Roe, HD White, DL BhattFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.